Myeloma specialists provide comprehensive insights on key data from the PERSEUS trial evaluating MRD status in patients receiving DARA-VRd and VRd.
Video content above is prompted by the following questions:
Stay up to date on recent advances in the multidisciplinary approach to cancer.